NYMXF (Nymox Pharmaceutical) Change In Prepaid Assets : $-0.50 Mil (TTM As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Nymox Pharmaceutical Change In Prepaid Assets?

Nymox Pharmaceutical's Change In Prepaid Assets for the quarter that ended in Sep. 2024 was $0.00 Mil. It means Nymox Pharmaceutical's Prepaid Assets stayed the same from Dec. 2023 to Sep. 2024 .

Nymox Pharmaceutical's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was $-0.50 Mil. It means Nymox Pharmaceutical's Prepaid Assets declined by $0.50 Mil from Dec. 2022 to Dec. 2023 .

Nymox Pharmaceutical Change In Prepaid Assets Historical Data

The historical data trend for Nymox Pharmaceutical's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nymox Pharmaceutical Change In Prepaid Assets Chart

Nymox Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Prepaid Assets

Get a 7-Day Free Trial

-0.01

-0.13

0.02

0.12

-0.50

Nymox Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Sep24
Change In Prepaid Assets	Get a 7-Day Free Trial															-0.06	0.03	-0.50	0.03	-

Nymox Pharmaceutical Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50 Mil.

Nymox Pharmaceutical Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Nymox Pharmaceutical's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nymox Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nymox Pharmaceutical Corp (OTCPK:NYMXF) » Definitions » Change In Prepaid Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bay & Deveaux Streets, Nassau, BHS

Website

https://www.nymox.com

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It operates in a single segment, which is research and development of products for the aging population. The company's geographical segments include Canada, United States, and Europe.

Executives

James George Robinson	director	10 EAST LEE STREET, SUITE 2705, BALTIMORE MD 21202
Erik Danielsen	officer: Chief Financial Officer	9900 CAVENDISH BLVD, ST LAURENT A8 H4M 2V2
Paul Averback	director, 10 percent owner, officer: CEO	C/O NYMOX PHARMACEUTICAL CORPORATION, 9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT A8 H4M 2V2
Randall J Lanham	director, officer: General Counsel